nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—L-DOPA—Melphalan—breast cancer	0.27	1	CrCrCtD
Aminosalicylic Acid—PTGS1—breast cancer	0.217	0.636	CbGaD
Aminosalicylic Acid—PTGS2—breast cancer	0.124	0.364	CbGaD
Aminosalicylic Acid—MPO—Carboplatin—breast cancer	0.0523	1	CbGbCtD
Aminosalicylic Acid—CHUK—epithelium—breast cancer	0.00214	0.0639	CbGeAlD
Aminosalicylic Acid—CHUK—skin of body—breast cancer	0.00203	0.0608	CbGeAlD
Aminosalicylic Acid—CHUK—adipose tissue—breast cancer	0.00173	0.0517	CbGeAlD
Aminosalicylic Acid—CHUK—female reproductive system—breast cancer	0.00159	0.0475	CbGeAlD
Aminosalicylic Acid—CHUK—adrenal gland—breast cancer	0.00155	0.0463	CbGeAlD
Aminosalicylic Acid—CHUK—female gonad—breast cancer	0.00144	0.0432	CbGeAlD
Aminosalicylic Acid—CHUK—endocrine gland—breast cancer	0.00134	0.0402	CbGeAlD
Aminosalicylic Acid—MPO—epithelium—breast cancer	0.00102	0.0305	CbGeAlD
Aminosalicylic Acid—ALOX5—adipose tissue—breast cancer	0.000972	0.0291	CbGeAlD
Aminosalicylic Acid—MPO—skin of body—breast cancer	0.000968	0.029	CbGeAlD
Aminosalicylic Acid—CHUK—lymph node—breast cancer	0.000928	0.0278	CbGeAlD
Aminosalicylic Acid—ALOX5—female reproductive system—breast cancer	0.000894	0.0268	CbGeAlD
Aminosalicylic Acid—ALOX5—adrenal gland—breast cancer	0.000872	0.0261	CbGeAlD
Aminosalicylic Acid—ALOX5—bone marrow—breast cancer	0.000844	0.0253	CbGeAlD
Aminosalicylic Acid—MPO—pituitary gland—breast cancer	0.000826	0.0247	CbGeAlD
Aminosalicylic Acid—ALOX5—female gonad—breast cancer	0.000813	0.0243	CbGeAlD
Aminosalicylic Acid—ALOX5—endocrine gland—breast cancer	0.000756	0.0226	CbGeAlD
Aminosalicylic Acid—MPO—adrenal gland—breast cancer	0.000738	0.0221	CbGeAlD
Aminosalicylic Acid—Methyldopa—COMT—breast cancer	0.000732	0.271	CrCbGaD
Aminosalicylic Acid—PTGS1—nipple—breast cancer	0.000717	0.0215	CbGeAlD
Aminosalicylic Acid—MPO—bone marrow—breast cancer	0.000714	0.0214	CbGeAlD
Aminosalicylic Acid—MPO—endocrine gland—breast cancer	0.00064	0.0192	CbGeAlD
Aminosalicylic Acid—PTGS2—embryo—breast cancer	0.000566	0.0169	CbGeAlD
Aminosalicylic Acid—ALOX5—lymph node—breast cancer	0.000523	0.0157	CbGeAlD
Aminosalicylic Acid—PTGS1—epithelium—breast cancer	0.000483	0.0145	CbGeAlD
Aminosalicylic Acid—PTGS2—epithelium—breast cancer	0.000462	0.0138	CbGeAlD
Aminosalicylic Acid—PTGS1—skin of body—breast cancer	0.000459	0.0138	CbGeAlD
Aminosalicylic Acid—MPO—lymph node—breast cancer	0.000442	0.0132	CbGeAlD
Aminosalicylic Acid—PTGS2—skin of body—breast cancer	0.000439	0.0131	CbGeAlD
Aminosalicylic Acid—PTGS1—endometrium—breast cancer	0.000433	0.013	CbGeAlD
Aminosalicylic Acid—PTGS2—endometrium—breast cancer	0.000414	0.0124	CbGeAlD
Aminosalicylic Acid—PTGS1—uterus—breast cancer	0.000399	0.0119	CbGeAlD
Aminosalicylic Acid—PTGS1—pituitary gland—breast cancer	0.000392	0.0117	CbGeAlD
Aminosalicylic Acid—PTGS1—adipose tissue—breast cancer	0.00039	0.0117	CbGeAlD
Aminosalicylic Acid—Diflunisal—PTGS1—breast cancer	0.000388	0.143	CrCbGaD
Aminosalicylic Acid—PTGS2—uterus—breast cancer	0.000381	0.0114	CbGeAlD
Aminosalicylic Acid—PTGS2—pituitary gland—breast cancer	0.000375	0.0112	CbGeAlD
Aminosalicylic Acid—PTGS2—adipose tissue—breast cancer	0.000373	0.0112	CbGeAlD
Aminosalicylic Acid—PTGS1—female reproductive system—breast cancer	0.000359	0.0107	CbGeAlD
Aminosalicylic Acid—PTGS1—adrenal gland—breast cancer	0.00035	0.0105	CbGeAlD
Aminosalicylic Acid—PTGS2—female reproductive system—breast cancer	0.000343	0.0103	CbGeAlD
Aminosalicylic Acid—PTGS2—adrenal gland—breast cancer	0.000335	0.01	CbGeAlD
Aminosalicylic Acid—PTGS1—female gonad—breast cancer	0.000326	0.00977	CbGeAlD
Aminosalicylic Acid—PTGS2—bone marrow—breast cancer	0.000324	0.00969	CbGeAlD
Aminosalicylic Acid—PTGS2—female gonad—breast cancer	0.000312	0.00934	CbGeAlD
Aminosalicylic Acid—Mesalazine—PTGS1—breast cancer	0.000304	0.113	CrCbGaD
Aminosalicylic Acid—PTGS1—endocrine gland—breast cancer	0.000304	0.00909	CbGeAlD
Aminosalicylic Acid—PTGS2—endocrine gland—breast cancer	0.00029	0.00869	CbGeAlD
Aminosalicylic Acid—Diflunisal—PTGS2—breast cancer	0.000222	0.082	CrCbGaD
Aminosalicylic Acid—Salicylic acid—PTGS1—breast cancer	0.000216	0.0798	CrCbGaD
Aminosalicylic Acid—PTGS1—lymph node—breast cancer	0.00021	0.00628	CbGeAlD
Aminosalicylic Acid—PTGS2—lymph node—breast cancer	0.000201	0.00601	CbGeAlD
Aminosalicylic Acid—Diflunisal—ALB—breast cancer	0.000197	0.0731	CrCbGaD
Aminosalicylic Acid—Mesalazine—PTGS2—breast cancer	0.000174	0.0644	CrCbGaD
Aminosalicylic Acid—L-DOPA—CYP2D6—breast cancer	0.000131	0.0486	CrCbGaD
Aminosalicylic Acid—Salicylic acid—PTGS2—breast cancer	0.000123	0.0456	CrCbGaD
Aminosalicylic Acid—Urinary tract disorder—Capecitabine—breast cancer	0.000122	0.000848	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Doxorubicin—breast cancer	0.000122	0.000848	CcSEcCtD
Aminosalicylic Acid—Anorexia—Gemcitabine—breast cancer	0.000122	0.000847	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vinblastine—breast cancer	0.000122	0.000846	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Goserelin—breast cancer	0.000122	0.000845	CcSEcCtD
Aminosalicylic Acid—Anaemia—Paclitaxel—breast cancer	0.000122	0.000842	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Capecitabine—breast cancer	0.000122	0.000842	CcSEcCtD
Aminosalicylic Acid—Urticaria—Thiotepa—breast cancer	0.000121	0.000839	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Thiotepa—breast cancer	0.000121	0.000835	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Thiotepa—breast cancer	0.000121	0.000835	CcSEcCtD
Aminosalicylic Acid—Headache—Vinblastine—breast cancer	0.00012	0.000833	CcSEcCtD
Aminosalicylic Acid—Anorexia—Fluorouracil—breast cancer	0.00012	0.000832	CcSEcCtD
Aminosalicylic Acid—Purpura—Doxorubicin—breast cancer	0.00012	0.00083	CcSEcCtD
Aminosalicylic Acid—Vomiting—Tamoxifen—breast cancer	0.000119	0.000822	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Doxorubicin—breast cancer	0.000118	0.00082	CcSEcCtD
Aminosalicylic Acid—Dizziness—Goserelin—breast cancer	0.000118	0.000816	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Paclitaxel—breast cancer	0.000118	0.000816	CcSEcCtD
Aminosalicylic Acid—Rash—Tamoxifen—breast cancer	0.000118	0.000815	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Vinorelbine—breast cancer	0.000118	0.000815	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Tamoxifen—breast cancer	0.000118	0.000814	CcSEcCtD
Aminosalicylic Acid—Headache—Tamoxifen—breast cancer	0.000117	0.00081	CcSEcCtD
Aminosalicylic Acid—Vomiting—Melphalan—breast cancer	0.000116	0.000805	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	0.000116	0.0008	CcSEcCtD
Aminosalicylic Acid—Rash—Melphalan—breast cancer	0.000115	0.000798	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Melphalan—breast cancer	0.000115	0.000797	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Mitoxantrone—breast cancer	0.000114	0.000793	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Irinotecan—breast cancer	0.000114	0.000793	CcSEcCtD
Aminosalicylic Acid—Nausea—Vinblastine—breast cancer	0.000114	0.00079	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Irinotecan—breast cancer	0.000114	0.000787	CcSEcCtD
Aminosalicylic Acid—Vomiting—Goserelin—breast cancer	0.000113	0.000785	CcSEcCtD
Aminosalicylic Acid—Rash—Goserelin—breast cancer	0.000112	0.000778	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Thiotepa—breast cancer	0.000112	0.000778	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Goserelin—breast cancer	0.000112	0.000778	CcSEcCtD
Aminosalicylic Acid—Headache—Goserelin—breast cancer	0.000112	0.000773	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Docetaxel—breast cancer	0.000111	0.000772	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Gemcitabine—breast cancer	0.000111	0.000772	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000111	0.00077	CcSEcCtD
Aminosalicylic Acid—Nausea—Tamoxifen—breast cancer	0.000111	0.000768	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000111	0.000767	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ALB—breast cancer	0.00011	0.0407	CrCbGaD
Aminosalicylic Acid—Decreased appetite—Fluorouracil—breast cancer	0.00011	0.000759	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Vinorelbine—breast cancer	0.000109	0.000756	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Docetaxel—breast cancer	0.000109	0.000756	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000109	0.000754	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Epirubicin—breast cancer	0.000109	0.000753	CcSEcCtD
Aminosalicylic Acid—Nausea—Melphalan—breast cancer	0.000109	0.000752	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Capecitabine—breast cancer	0.000108	0.000748	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000108	0.000746	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Irinotecan—breast cancer	0.000108	0.000746	CcSEcCtD
Aminosalicylic Acid—Flatulence—Capecitabine—breast cancer	0.000106	0.000737	CcSEcCtD
Aminosalicylic Acid—Nausea—Goserelin—breast cancer	0.000106	0.000733	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Capecitabine—breast cancer	0.000106	0.000732	CcSEcCtD
Aminosalicylic Acid—Dizziness—Vinorelbine—breast cancer	0.000106	0.000731	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Paclitaxel—breast cancer	0.000105	0.000729	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Paclitaxel—breast cancer	0.000105	0.000728	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ABCB1—breast cancer	0.000105	0.0388	CrCbGaD
Aminosalicylic Acid—Urticaria—Mitoxantrone—breast cancer	0.000105	0.000724	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Thiotepa—breast cancer	0.000104	0.000722	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Paclitaxel—breast cancer	0.000104	0.000722	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Mitoxantrone—breast cancer	0.000104	0.000721	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Mitoxantrone—breast cancer	0.000104	0.000721	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Irinotecan—breast cancer	0.000104	0.000721	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Irinotecan—breast cancer	0.000104	0.000721	CcSEcCtD
Aminosalicylic Acid—Anaemia—Docetaxel—breast cancer	0.000103	0.000714	CcSEcCtD
Aminosalicylic Acid—Anorexia—Paclitaxel—breast cancer	0.000102	0.000709	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vinorelbine—breast cancer	0.000101	0.000703	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Gemcitabine—breast cancer	0.000101	0.000702	CcSEcCtD
Aminosalicylic Acid—Dizziness—Thiotepa—breast cancer	0.000101	0.000698	CcSEcCtD
Aminosalicylic Acid—Rash—Vinorelbine—breast cancer	0.000101	0.000697	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Vinorelbine—breast cancer	0.000101	0.000696	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Doxorubicin—breast cancer	0.000101	0.000696	CcSEcCtD
Aminosalicylic Acid—Urticaria—Fluorouracil—breast cancer	0.0001	0.000694	CcSEcCtD
Aminosalicylic Acid—Headache—Vinorelbine—breast cancer	0.0001	0.000693	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Docetaxel—breast cancer	9.98e-05	0.000691	CcSEcCtD
Aminosalicylic Acid—Anaemia—Capecitabine—breast cancer	9.98e-05	0.000691	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Fluorouracil—breast cancer	9.97e-05	0.00069	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Epirubicin—breast cancer	9.76e-05	0.000676	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Irinotecan—breast cancer	9.7e-05	0.000672	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Mitoxantrone—breast cancer	9.7e-05	0.000672	CcSEcCtD
Aminosalicylic Acid—Vomiting—Thiotepa—breast cancer	9.69e-05	0.000671	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Capecitabine—breast cancer	9.66e-05	0.000669	CcSEcCtD
Aminosalicylic Acid—Rash—Thiotepa—breast cancer	9.61e-05	0.000666	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Thiotepa—breast cancer	9.6e-05	0.000665	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Methotrexate—breast cancer	9.6e-05	0.000665	CcSEcCtD
Aminosalicylic Acid—Headache—Thiotepa—breast cancer	9.55e-05	0.000661	CcSEcCtD
Aminosalicylic Acid—Nausea—Vinorelbine—breast cancer	9.48e-05	0.000657	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Epirubicin—breast cancer	9.43e-05	0.000653	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	9.43e-05	0.000653	CcSEcCtD
Aminosalicylic Acid—Jaundice—Epirubicin—breast cancer	9.38e-05	0.00065	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Paclitaxel—breast cancer	9.33e-05	0.000646	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Fluorouracil—breast cancer	9.29e-05	0.000643	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Paclitaxel—breast cancer	9.27e-05	0.000642	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Methotrexate—breast cancer	9.23e-05	0.000639	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	9.13e-05	0.000632	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Methotrexate—breast cancer	9.12e-05	0.000631	CcSEcCtD
Aminosalicylic Acid—Nausea—Thiotepa—breast cancer	9.05e-05	0.000627	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Methotrexate—breast cancer	9.05e-05	0.000627	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Doxorubicin—breast cancer	9.04e-05	0.000626	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Mitoxantrone—breast cancer	9.01e-05	0.000624	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Irinotecan—breast cancer	9.01e-05	0.000624	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Epirubicin—breast cancer	8.98e-05	0.000622	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Docetaxel—breast cancer	8.92e-05	0.000618	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Docetaxel—breast cancer	8.91e-05	0.000617	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Docetaxel—breast cancer	8.84e-05	0.000612	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Paclitaxel—breast cancer	8.78e-05	0.000608	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Gemcitabine—breast cancer	8.77e-05	0.000608	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Doxorubicin—breast cancer	8.73e-05	0.000605	CcSEcCtD
Aminosalicylic Acid—Dizziness—Irinotecan—breast cancer	8.7e-05	0.000603	CcSEcCtD
Aminosalicylic Acid—Jaundice—Doxorubicin—breast cancer	8.68e-05	0.000601	CcSEcCtD
Aminosalicylic Acid—Anorexia—Docetaxel—breast cancer	8.67e-05	0.000601	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Capecitabine—breast cancer	8.64e-05	0.000598	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Epirubicin—breast cancer	8.64e-05	0.000598	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Fluorouracil—breast cancer	8.63e-05	0.000597	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Capecitabine—breast cancer	8.63e-05	0.000597	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Capecitabine—breast cancer	8.56e-05	0.000593	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Epirubicin—breast cancer	8.53e-05	0.000591	CcSEcCtD
Aminosalicylic Acid—Urticaria—Paclitaxel—breast cancer	8.53e-05	0.000591	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Paclitaxel—breast cancer	8.49e-05	0.000588	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Paclitaxel—breast cancer	8.49e-05	0.000588	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Epirubicin—breast cancer	8.47e-05	0.000587	CcSEcCtD
Aminosalicylic Acid—Anorexia—Capecitabine—breast cancer	8.4e-05	0.000582	CcSEcCtD
Aminosalicylic Acid—Vomiting—Mitoxantrone—breast cancer	8.37e-05	0.00058	CcSEcCtD
Aminosalicylic Acid—Vomiting—Irinotecan—breast cancer	8.37e-05	0.00058	CcSEcCtD
Aminosalicylic Acid—Dizziness—Fluorouracil—breast cancer	8.34e-05	0.000577	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Doxorubicin—breast cancer	8.31e-05	0.000576	CcSEcCtD
Aminosalicylic Acid—Rash—Mitoxantrone—breast cancer	8.3e-05	0.000575	CcSEcCtD
Aminosalicylic Acid—Rash—Irinotecan—breast cancer	8.3e-05	0.000575	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Mitoxantrone—breast cancer	8.29e-05	0.000574	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Irinotecan—breast cancer	8.29e-05	0.000574	CcSEcCtD
Aminosalicylic Acid—Headache—Mitoxantrone—breast cancer	8.25e-05	0.000571	CcSEcCtD
Aminosalicylic Acid—Headache—Irinotecan—breast cancer	8.25e-05	0.000571	CcSEcCtD
Aminosalicylic Acid—Vomiting—Gemcitabine—breast cancer	8.15e-05	0.000565	CcSEcCtD
Aminosalicylic Acid—Rash—Gemcitabine—breast cancer	8.09e-05	0.00056	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Gemcitabine—breast cancer	8.08e-05	0.000559	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methotrexate—breast cancer	8.04e-05	0.000557	CcSEcCtD
Aminosalicylic Acid—Headache—Gemcitabine—breast cancer	8.03e-05	0.000556	CcSEcCtD
Aminosalicylic Acid—Vomiting—Fluorouracil—breast cancer	8.02e-05	0.000555	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Doxorubicin—breast cancer	7.99e-05	0.000554	CcSEcCtD
Aminosalicylic Acid—Rash—Fluorouracil—breast cancer	7.95e-05	0.000551	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Fluorouracil—breast cancer	7.94e-05	0.00055	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Docetaxel—breast cancer	7.91e-05	0.000548	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Paclitaxel—breast cancer	7.91e-05	0.000548	CcSEcCtD
Aminosalicylic Acid—Headache—Fluorouracil—breast cancer	7.9e-05	0.000547	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Doxorubicin—breast cancer	7.89e-05	0.000547	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Methotrexate—breast cancer	7.87e-05	0.000545	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Docetaxel—breast cancer	7.86e-05	0.000544	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Doxorubicin—breast cancer	7.84e-05	0.000543	CcSEcCtD
Aminosalicylic Acid—Nausea—Irinotecan—breast cancer	7.82e-05	0.000542	CcSEcCtD
Aminosalicylic Acid—Nausea—Mitoxantrone—breast cancer	7.82e-05	0.000542	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Capecitabine—breast cancer	7.66e-05	0.00053	CcSEcCtD
Aminosalicylic Acid—Nausea—Gemcitabine—breast cancer	7.62e-05	0.000528	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Capecitabine—breast cancer	7.61e-05	0.000527	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Epirubicin—breast cancer	7.52e-05	0.000521	CcSEcCtD
Aminosalicylic Acid—Nausea—Fluorouracil—breast cancer	7.49e-05	0.000519	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Docetaxel—breast cancer	7.44e-05	0.000515	CcSEcCtD
Aminosalicylic Acid—Anaemia—Methotrexate—breast cancer	7.43e-05	0.000514	CcSEcCtD
Aminosalicylic Acid—Flatulence—Epirubicin—breast cancer	7.41e-05	0.000513	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Epirubicin—breast cancer	7.36e-05	0.00051	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Paclitaxel—breast cancer	7.35e-05	0.000509	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Capecitabine—breast cancer	7.2e-05	0.000499	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Docetaxel—breast cancer	7.19e-05	0.000498	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Docetaxel—breast cancer	7.19e-05	0.000498	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Methotrexate—breast cancer	7.19e-05	0.000498	CcSEcCtD
Aminosalicylic Acid—Dizziness—Paclitaxel—breast cancer	7.1e-05	0.000492	CcSEcCtD
Aminosalicylic Acid—Urticaria—Capecitabine—breast cancer	7e-05	0.000485	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Capecitabine—breast cancer	6.96e-05	0.000482	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Capecitabine—breast cancer	6.96e-05	0.000482	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Doxorubicin—breast cancer	6.96e-05	0.000482	CcSEcCtD
Aminosalicylic Acid—Anaemia—Epirubicin—breast cancer	6.95e-05	0.000481	CcSEcCtD
Aminosalicylic Acid—Flatulence—Doxorubicin—breast cancer	6.86e-05	0.000475	CcSEcCtD
Aminosalicylic Acid—Vomiting—Paclitaxel—breast cancer	6.83e-05	0.000473	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Doxorubicin—breast cancer	6.81e-05	0.000472	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	6.79e-05	0.000471	CcSEcCtD
Aminosalicylic Acid—Rash—Paclitaxel—breast cancer	6.77e-05	0.000469	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Paclitaxel—breast cancer	6.76e-05	0.000468	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Epirubicin—breast cancer	6.73e-05	0.000466	CcSEcCtD
Aminosalicylic Acid—Headache—Paclitaxel—breast cancer	6.73e-05	0.000466	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Docetaxel—breast cancer	6.7e-05	0.000464	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Capecitabine—breast cancer	6.49e-05	0.00045	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Methotrexate—breast cancer	6.43e-05	0.000445	CcSEcCtD
Aminosalicylic Acid—Anaemia—Doxorubicin—breast cancer	6.43e-05	0.000445	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Methotrexate—breast cancer	6.42e-05	0.000445	CcSEcCtD
Aminosalicylic Acid—Nausea—Paclitaxel—breast cancer	6.38e-05	0.000442	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methotrexate—breast cancer	6.37e-05	0.000441	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.36e-05	0.00044	CcSEcCtD
Aminosalicylic Acid—Anorexia—Methotrexate—breast cancer	6.25e-05	0.000433	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Doxorubicin—breast cancer	6.23e-05	0.000431	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Docetaxel—breast cancer	6.23e-05	0.000431	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Capecitabine—breast cancer	6.03e-05	0.000418	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Epirubicin—breast cancer	6.02e-05	0.000417	CcSEcCtD
Aminosalicylic Acid—Dizziness—Docetaxel—breast cancer	6.02e-05	0.000417	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Epirubicin—breast cancer	6.01e-05	0.000416	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Epirubicin—breast cancer	5.96e-05	0.000413	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.88e-05	0.000408	CcSEcCtD
Aminosalicylic Acid—Anorexia—Epirubicin—breast cancer	5.85e-05	0.000405	CcSEcCtD
Aminosalicylic Acid—Dizziness—Capecitabine—breast cancer	5.83e-05	0.000404	CcSEcCtD
Aminosalicylic Acid—Vomiting—Docetaxel—breast cancer	5.79e-05	0.000401	CcSEcCtD
Aminosalicylic Acid—Rash—Docetaxel—breast cancer	5.74e-05	0.000397	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Docetaxel—breast cancer	5.73e-05	0.000397	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Methotrexate—breast cancer	5.7e-05	0.000395	CcSEcCtD
Aminosalicylic Acid—Headache—Docetaxel—breast cancer	5.7e-05	0.000395	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Methotrexate—breast cancer	5.66e-05	0.000392	CcSEcCtD
Aminosalicylic Acid—Vomiting—Capecitabine—breast cancer	5.6e-05	0.000388	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Doxorubicin—breast cancer	5.57e-05	0.000386	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Doxorubicin—breast cancer	5.56e-05	0.000385	CcSEcCtD
Aminosalicylic Acid—Rash—Capecitabine—breast cancer	5.56e-05	0.000385	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Capecitabine—breast cancer	5.55e-05	0.000384	CcSEcCtD
Aminosalicylic Acid—Headache—Capecitabine—breast cancer	5.52e-05	0.000382	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Doxorubicin—breast cancer	5.52e-05	0.000382	CcSEcCtD
Aminosalicylic Acid—Anorexia—Doxorubicin—breast cancer	5.41e-05	0.000375	CcSEcCtD
Aminosalicylic Acid—Nausea—Docetaxel—breast cancer	5.41e-05	0.000374	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methotrexate—breast cancer	5.36e-05	0.000371	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Epirubicin—breast cancer	5.34e-05	0.00037	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Epirubicin—breast cancer	5.3e-05	0.000367	CcSEcCtD
Aminosalicylic Acid—Nausea—Capecitabine—breast cancer	5.23e-05	0.000362	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methotrexate—breast cancer	5.21e-05	0.000361	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methotrexate—breast cancer	5.18e-05	0.000359	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Methotrexate—breast cancer	5.18e-05	0.000359	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Epirubicin—breast cancer	5.02e-05	0.000348	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Doxorubicin—breast cancer	4.94e-05	0.000342	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Doxorubicin—breast cancer	4.9e-05	0.00034	CcSEcCtD
Aminosalicylic Acid—Urticaria—Epirubicin—breast cancer	4.88e-05	0.000338	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Epirubicin—breast cancer	4.85e-05	0.000336	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Epirubicin—breast cancer	4.85e-05	0.000336	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methotrexate—breast cancer	4.83e-05	0.000335	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Doxorubicin—breast cancer	4.64e-05	0.000322	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Epirubicin—breast cancer	4.52e-05	0.000313	CcSEcCtD
Aminosalicylic Acid—Urticaria—Doxorubicin—breast cancer	4.51e-05	0.000312	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Doxorubicin—breast cancer	4.49e-05	0.000311	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Doxorubicin—breast cancer	4.49e-05	0.000311	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methotrexate—breast cancer	4.49e-05	0.000311	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methotrexate—breast cancer	4.34e-05	0.0003	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Epirubicin—breast cancer	4.2e-05	0.000291	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Doxorubicin—breast cancer	4.18e-05	0.00029	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methotrexate—breast cancer	4.17e-05	0.000289	CcSEcCtD
Aminosalicylic Acid—Rash—Methotrexate—breast cancer	4.14e-05	0.000286	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methotrexate—breast cancer	4.13e-05	0.000286	CcSEcCtD
Aminosalicylic Acid—Headache—Methotrexate—breast cancer	4.11e-05	0.000285	CcSEcCtD
Aminosalicylic Acid—Dizziness—Epirubicin—breast cancer	4.06e-05	0.000281	CcSEcCtD
Aminosalicylic Acid—Vomiting—Epirubicin—breast cancer	3.9e-05	0.00027	CcSEcCtD
Aminosalicylic Acid—Nausea—Methotrexate—breast cancer	3.9e-05	0.00027	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Doxorubicin—breast cancer	3.89e-05	0.000269	CcSEcCtD
Aminosalicylic Acid—Rash—Epirubicin—breast cancer	3.87e-05	0.000268	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Epirubicin—breast cancer	3.87e-05	0.000268	CcSEcCtD
Aminosalicylic Acid—Headache—Epirubicin—breast cancer	3.85e-05	0.000266	CcSEcCtD
Aminosalicylic Acid—Dizziness—Doxorubicin—breast cancer	3.76e-05	0.00026	CcSEcCtD
Aminosalicylic Acid—Nausea—Epirubicin—breast cancer	3.65e-05	0.000253	CcSEcCtD
Aminosalicylic Acid—Vomiting—Doxorubicin—breast cancer	3.61e-05	0.00025	CcSEcCtD
Aminosalicylic Acid—Rash—Doxorubicin—breast cancer	3.58e-05	0.000248	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Doxorubicin—breast cancer	3.58e-05	0.000248	CcSEcCtD
Aminosalicylic Acid—Headache—Doxorubicin—breast cancer	3.56e-05	0.000246	CcSEcCtD
Aminosalicylic Acid—Nausea—Doxorubicin—breast cancer	3.37e-05	0.000234	CcSEcCtD
Aminosalicylic Acid—PTGS2—Metabolism—PTGS1—breast cancer	5.56e-06	3.56e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.54e-06	3.55e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HSP90AA1—breast cancer	5.54e-06	3.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SMAD4—breast cancer	5.49e-06	3.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.47e-06	3.5e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1R—breast cancer	5.46e-06	3.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP2D6—breast cancer	5.45e-06	3.49e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGFR—breast cancer	5.44e-06	3.48e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTEN—breast cancer	5.4e-06	3.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CD—breast cancer	5.39e-06	3.45e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PRL—breast cancer	5.38e-06	3.45e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HES1—breast cancer	5.37e-06	3.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NCOA2—breast cancer	5.35e-06	3.43e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KRAS—breast cancer	5.35e-06	3.43e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PLA2G4A—breast cancer	5.33e-06	3.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NCOR1—breast cancer	5.33e-06	3.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—BRAF—breast cancer	5.32e-06	3.41e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ADAM10—breast cancer	5.31e-06	3.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CSF2—breast cancer	5.27e-06	3.38e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF1—breast cancer	5.27e-06	3.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.26e-06	3.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NRG1—breast cancer	5.24e-06	3.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—COMT—breast cancer	5.2e-06	3.34e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—H2AFX—breast cancer	5.2e-06	3.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—FASN—breast cancer	5.19e-06	3.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTP1—breast cancer	5.18e-06	3.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT2—breast cancer	5.18e-06	3.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—BCHE—breast cancer	5.17e-06	3.31e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF10—breast cancer	5.16e-06	3.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—E2F1—breast cancer	5.16e-06	3.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KRAS—breast cancer	5.14e-06	3.29e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HMOX1—breast cancer	5.11e-06	3.27e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC5A5—breast cancer	5.11e-06	3.27e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ITPR1—breast cancer	5.1e-06	3.27e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PDGFA—breast cancer	4.98e-06	3.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CD—breast cancer	4.97e-06	3.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SPP1—breast cancer	4.96e-06	3.18e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NQO1—breast cancer	4.93e-06	3.16e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC2A1—breast cancer	4.93e-06	3.16e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SERPINE1—breast cancer	4.92e-06	3.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PIK3CA—breast cancer	4.91e-06	3.15e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFBR2—breast cancer	4.91e-06	3.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB3—breast cancer	4.91e-06	3.14e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCB1—breast cancer	4.9e-06	3.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGFR2—breast cancer	4.9e-06	3.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2—breast cancer	4.9e-06	3.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—breast cancer	4.85e-06	3.11e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ITPR1—breast cancer	4.83e-06	3.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.83e-06	3.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MDM2—breast cancer	4.82e-06	3.09e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TYMS—breast cancer	4.82e-06	3.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RAF1—breast cancer	4.81e-06	3.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP3A4—breast cancer	4.81e-06	3.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB4—breast cancer	4.8e-06	3.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT5A—breast cancer	4.8e-06	3.08e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RELA—breast cancer	4.79e-06	3.07e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PLA2G4A—breast cancer	4.76e-06	3.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTM1—breast cancer	4.76e-06	3.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NCOR1—breast cancer	4.76e-06	3.05e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ERBB2—breast cancer	4.76e-06	3.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP1B1—breast cancer	4.73e-06	3.03e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CA—breast cancer	4.72e-06	3.02e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TERT—breast cancer	4.7e-06	3.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS3—breast cancer	4.7e-06	3.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CB—breast cancer	4.69e-06	3.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MTOR—breast cancer	4.69e-06	3.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD4—breast cancer	4.69e-06	3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SMAD4—breast cancer	4.65e-06	2.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HSP90AA1—breast cancer	4.64e-06	2.97e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGFR1—breast cancer	4.56e-06	2.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GPX1—breast cancer	4.56e-06	2.92e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HRAS—breast cancer	4.55e-06	2.91e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HES1—breast cancer	4.54e-06	2.91e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP1A1—breast cancer	4.51e-06	2.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NCOR1—breast cancer	4.51e-06	2.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NCOA1—breast cancer	4.51e-06	2.89e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HIF1A—breast cancer	4.5e-06	2.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ERCC2—breast cancer	4.48e-06	2.87e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF1—breast cancer	4.46e-06	2.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MDM2—breast cancer	4.45e-06	2.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—STK11—breast cancer	4.44e-06	2.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP19A1—breast cancer	4.44e-06	2.85e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RAF1—breast cancer	4.44e-06	2.84e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NRG1—breast cancer	4.43e-06	2.84e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1B—breast cancer	4.41e-06	2.82e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—H2AFX—breast cancer	4.4e-06	2.82e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ERBB2—breast cancer	4.39e-06	2.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LEP—breast cancer	4.39e-06	2.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HRAS—breast cancer	4.37e-06	2.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—breast cancer	4.35e-06	2.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CAV1—breast cancer	4.35e-06	2.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CB—breast cancer	4.33e-06	2.78e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTOR—breast cancer	4.33e-06	2.78e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1B—breast cancer	4.33e-06	2.77e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD4—breast cancer	4.33e-06	2.77e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—breast cancer	4.31e-06	2.76e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KDR—breast cancer	4.3e-06	2.76e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—breast cancer	4.29e-06	2.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERCC2—breast cancer	4.24e-06	2.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—breast cancer	4.21e-06	2.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—JUN—breast cancer	4.19e-06	2.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ESR1—breast cancer	4.19e-06	2.69e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.17e-06	2.67e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTNNB1—breast cancer	4.16e-06	2.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB3—breast cancer	4.15e-06	2.66e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGFR2—breast cancer	4.14e-06	2.65e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FN1—breast cancer	4.14e-06	2.65e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—COMT—breast cancer	4.13e-06	2.65e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTP1—breast cancer	4.11e-06	2.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NFKBIA—breast cancer	4.09e-06	2.62e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1B—breast cancer	4.07e-06	2.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1A—breast cancer	4.07e-06	2.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTEN—breast cancer	4.06e-06	2.6e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HMOX1—breast cancer	4.06e-06	2.6e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH1—breast cancer	4.05e-06	2.6e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ITPR1—breast cancer	4.05e-06	2.59e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—breast cancer	4.01e-06	2.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—breast cancer	3.99e-06	2.56e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TERT—breast cancer	3.98e-06	2.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK8—breast cancer	3.97e-06	2.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APC—breast cancer	3.96e-06	2.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CG—breast cancer	3.96e-06	2.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KIT—breast cancer	3.96e-06	2.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGF—breast cancer	3.92e-06	2.51e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCB1—breast cancer	3.89e-06	2.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CAV1—breast cancer	3.88e-06	2.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGFR1—breast cancer	3.86e-06	2.47e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—breast cancer	3.85e-06	2.47e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CTNNB1—breast cancer	3.84e-06	2.46e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TYMS—breast cancer	3.82e-06	2.45e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CA—breast cancer	3.81e-06	2.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HIF1A—breast cancer	3.8e-06	2.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NCOR1—breast cancer	3.78e-06	2.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTM1—breast cancer	3.78e-06	2.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PLA2G4A—breast cancer	3.78e-06	2.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SRC—breast cancer	3.76e-06	2.41e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1A—breast cancer	3.75e-06	2.41e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTEN—breast cancer	3.75e-06	2.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BRAF—breast cancer	3.72e-06	2.39e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.71e-06	2.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CAV1—breast cancer	3.68e-06	2.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT3—breast cancer	3.63e-06	2.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1—breast cancer	3.63e-06	2.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT2—breast cancer	3.62e-06	2.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GPX1—breast cancer	3.62e-06	2.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP1A1—breast cancer	3.58e-06	2.3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ERCC2—breast cancer	3.55e-06	2.28e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CG—breast cancer	3.53e-06	2.27e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CD—breast cancer	3.48e-06	2.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SRC—breast cancer	3.47e-06	2.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK3—breast cancer	3.47e-06	2.22e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS2—breast cancer	3.46e-06	2.22e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SERPINE1—breast cancer	3.44e-06	2.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOTCH1—breast cancer	3.43e-06	2.2e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APC—breast cancer	3.35e-06	2.15e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KIT—breast cancer	3.35e-06	2.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—STAT3—breast cancer	3.35e-06	2.15e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—breast cancer	3.34e-06	2.14e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGF—breast cancer	3.31e-06	2.12e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGFR—breast cancer	3.3e-06	2.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOS3—breast cancer	3.29e-06	2.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAPK3—breast cancer	3.2e-06	2.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—BRAF—breast cancer	3.15e-06	2.02e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MDM2—breast cancer	3.12e-06	2e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KRAS—breast cancer	3.11e-06	2e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—breast cancer	3.11e-06	1.99e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—breast cancer	3.11e-06	1.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RAF1—breast cancer	3.11e-06	1.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CD—breast cancer	3.11e-06	1.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—breast cancer	3.1e-06	1.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RELA—breast cancer	3.1e-06	1.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CAV1—breast cancer	3.08e-06	1.97e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB2—breast cancer	3.08e-06	1.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—breast cancer	3.07e-06	1.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT2—breast cancer	3.07e-06	1.96e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGFR—breast cancer	3.04e-06	1.95e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MTOR—breast cancer	3.04e-06	1.94e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CB—breast cancer	3.04e-06	1.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CD—breast cancer	2.95e-06	1.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.94e-06	1.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NOS3—breast cancer	2.93e-06	1.88e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL8—breast cancer	2.92e-06	1.87e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SERPINE1—breast cancer	2.91e-06	1.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KRAS—breast cancer	2.88e-06	1.84e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CA—breast cancer	2.86e-06	1.83e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1B—breast cancer	2.85e-06	1.83e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CG—breast cancer	2.81e-06	1.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP3—breast cancer	2.79e-06	1.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—breast cancer	2.79e-06	1.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS3—breast cancer	2.78e-06	1.78e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCND1—breast cancer	2.72e-06	1.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JUN—breast cancer	2.71e-06	1.74e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CB—breast cancer	2.71e-06	1.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CTNNB1—breast cancer	2.69e-06	1.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—breast cancer	2.68e-06	1.72e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HRAS—breast cancer	2.65e-06	1.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CA—breast cancer	2.64e-06	1.69e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MDM2—breast cancer	2.64e-06	1.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—breast cancer	2.64e-06	1.69e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RAF1—breast cancer	2.63e-06	1.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1A—breast cancer	2.63e-06	1.68e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTEN—breast cancer	2.62e-06	1.68e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB2—breast cancer	2.6e-06	1.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTOR—breast cancer	2.57e-06	1.65e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CB—breast cancer	2.57e-06	1.65e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK8—breast cancer	2.57e-06	1.64e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD4—breast cancer	2.56e-06	1.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—breast cancer	2.53e-06	1.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CD—breast cancer	2.47e-06	1.58e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HRAS—breast cancer	2.44e-06	1.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—breast cancer	2.44e-06	1.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SRC—breast cancer	2.43e-06	1.56e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1B—breast cancer	2.41e-06	1.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—breast cancer	2.37e-06	1.52e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT3—breast cancer	2.35e-06	1.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTEN—breast cancer	2.34e-06	1.5e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—breast cancer	2.34e-06	1.5e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—breast cancer	2.34e-06	1.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NOS3—breast cancer	2.33e-06	1.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CTNNB1—breast cancer	2.28e-06	1.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK3—breast cancer	2.24e-06	1.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1A—breast cancer	2.22e-06	1.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTEN—breast cancer	2.22e-06	1.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—breast cancer	2.18e-06	1.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—breast cancer	2.17e-06	1.39e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—breast cancer	2.16e-06	1.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CB—breast cancer	2.15e-06	1.38e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGFR—breast cancer	2.13e-06	1.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SRC—breast cancer	2.06e-06	1.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KRAS—breast cancer	2.01e-06	1.29e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT3—breast cancer	1.98e-06	1.27e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAPK3—breast cancer	1.9e-06	1.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTEN—breast cancer	1.86e-06	1.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CA—breast cancer	1.85e-06	1.19e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—breast cancer	1.84e-06	1.18e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—breast cancer	1.84e-06	1.18e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGFR—breast cancer	1.8e-06	1.16e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—breast cancer	1.79e-06	1.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRAS—breast cancer	1.71e-06	1.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KRAS—breast cancer	1.7e-06	1.09e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CA—breast cancer	1.65e-06	1.06e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—breast cancer	1.64e-06	1.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CA—breast cancer	1.57e-06	1e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—breast cancer	1.51e-06	9.69e-06	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HRAS—breast cancer	1.45e-06	9.28e-06	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—breast cancer	1.39e-06	8.88e-06	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—breast cancer	1.35e-06	8.64e-06	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CA—breast cancer	1.31e-06	8.4e-06	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—breast cancer	1.28e-06	8.19e-06	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—breast cancer	1.07e-06	6.86e-06	CbGpPWpGaD
